Early research (Phase 1)Study completedNCT00445913
What this trial is testing
Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
Who this might be right for
Type 1 Diabetes
University of Pittsburgh 10
Showing 20 of 0 results